2-Azaspiro[3.4]octane Hydrochloride - CAS 1414885-15-6

Name: 2-Azaspiro[3.4]octane Hydrochloride
Brand: BOC Sciences
Rating: 5 (1 reviews)

Catalog:	BB061230
Product Name:	2-Azaspiro[3.4]octane Hydrochloride
CAS:	1414885-15-6
Synonyms:	2-azaspiro[3.4]octane hydrochloride; 2-azaspiro[3.4]octane hcl; 2-azaspiro[3.4]octane; hydrochloride; 2-azaspiro[3.4]octanehydrochloride; 2-azaspiro[3,4]octane hydrochloride

Technical Data

IUPAC Name:	2-azaspiro[3.4]octanehydrochloride
Description:	2-Azaspiro[3.4]octane Hydrochloride is used as a reactant in the preparation of amines via titanium/polymethylhydrosiloxane-mediated reduction of nitriles.
Molecular Weight:	147.65
Molecular Formula:	C7H13N·HCl
Canonical SMILES:	C1CCC2(C1)CNC2.Cl
InChI:	InChI=1S/C7H13N.ClH/c1-2-4-7(3-1)5-8-6-7/h8H,1-6H21H
InChI Key:	HGTKRTFHRJSJLP-UHFFFAOYSA-N
References:	Laval, S., et al. Tetrahedron, 70, 975 (2014).

GHS Hazard Statement:	H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]
Precautionary Statement:	P261, P264, P264+P265, P271, P280, P302+P352, P304+P340, P305+P351+P338, P319, P321, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501
Signal Word:	Warning

Publication Number	Title	Priority Date
TW-202104236-A	New heterocyclic compounds	20190409
AU-2013354114-B2	Pyridine-2-amides useful as CB2 agonists	20121207
CN-103748080-A	Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereof	20110526
CN-103748080-B	Quinazoline derivative species tyrosine kinase inhibitor and preparation method and application	20110526
DK-2716633-T3	QUINAZOLINE DERIVATIVE AS A TYROSIN-KINASE INHIBITOR, PROCEDURE FOR PREPARING IT AND USING THEREOF	20110526
EP-2716633-A1	Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereof	20110526
EP-2716633-B1	Quinazoline derivative as tyrosine-kinase inhibitor, preparation method therefor and application thereof	20110526
HU-E033575-T2	Tyrosine kinase inhibitor quinazoline derivative, method of preparation and use	20110526
JP-2014515358-A	Quinazoline derivatives as tyrosine kinase inhibitors, their preparation and use	20110526
JP-5859118-B2	Quinazoline derivatives as tyrosine kinase inhibitors, their preparation and use	20110526

Complexity:	86.6
Compound Is Canonicalized:	Yes
Covalently-Bonded Unit Count:	2
Defined Atom Stereocenter Count:	0
Defined Bond Stereocenter Count:	0
Exact Mass:	147.0814771
Formal Charge:	0
Heavy Atom Count:	9
Hydrogen Bond Acceptor Count:	1
Hydrogen Bond Donor Count:	2
Isotope Atom Count:	0
Monoisotopic Mass:	147.0814771
Rotatable Bond Count:	0
Topological Polar Surface Area:	12Å²
Undefined Atom Stereocenter Count:	0
Undefined Bond Stereocenter Count:	0